Samantha Du | Founder, Chairperson and Chief Executive Officer |
Josh Smiley | Chief Operating Officer |
Billy Cho | Chief Financial Officer |
Alan Sandler | President, Head of Global Development, Oncology |
Harald Reinhart | President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases |
Jonathan Wang | Chief Business Development |
Michael Yee | Jefferies |
Yigal Nochomovitz | Citi |
Anupam Rama | J.P. Morgan |
Jonathan Chang | SVB Leerink |
Ziyi Chen | Goldman Sachs |
Seamus Fernandez | Guggenheim |
Yang Huang | Credit Suisse |
Hello, ladies and gentlemen, thank you for standing by and welcome to Zai Lab's Second Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, today's call is being recorded. It is now my pleasure to turn the floor over to Billy Cho, Chief Financial Officer of Zai Lab, who will make introductory comments.